ATOGEPANT FOR THE PREVENTION OF MIGRAINES
Article of the Month by David Burke Monoclonal antibodies that target calcitonin gene–related peptide (CGRP) have been introduced to reduce onset of migraines. Atogepant is…
Article of the Month by David Burke Monoclonal antibodies that target calcitonin gene–related peptide (CGRP) have been introduced to reduce onset of migraines. Atogepant is…
Thank you for your interest in the 2nd Edition of the ISPRM International Rehabilitation Week (November 29th-December 3rd, 2021) on the topic: Rehabilitation for Healthy…
Prof. Franco Franchignoni has recently received the Herman J. Flax award which was established by the International Rehabilitation Medicine Association in honour of Herman Flax…
The 2022 congress in Lisbon will be the biggest PRM event in the world. For the first time the International Society Congress (ISPRM), the European…
The ISPRM Disaster Rehabilitation Committee (DRC) Annual Meeting 2021 was held virtually on 7th October 2021, 9:00 – 10:00 pm (Australia EST). This session followed…
ISPRM has submitted statements to agenda items 14.2, 14.4 and 10 of the 72nd session of the WHO Regional Committee Meeting (RCM) for the Western…
Written by: Dra. Constanza Leal, Universidad de Chile, Country Ambassador Chile WYF-ISPRM In March 2020, the first case of SARS-CoV2 infection was detected in Chile. This…
Dr Catherine Velasquez on her Journey to become a PRM Doctor Abroad. Catherine Velasquez, MD: I am a foreign medical graduate from Peru and successfully matched into…
ISPRM has published a cross sectional study about the impact of COVID19 Pandemic in the PMR Residencies of 14 countries in the Americas. This study…
Globally, there is an increase in the ageing and non-communicable disease population as well as consequences of injuries. These result in limitations in the everyday…